表紙
市場調查報告書

AI支援醫療圖像解決方案的全球市場 - 分析與預測:法規方案,工作流程,治療用途,部署模型,模式,19個國家的資料,競爭情形 (2019-2029年)

Global AI-Enabled Medical Imaging Solutions Market: Focus on Regulatory Scenario, Workflow, Therapeutic Application, Deployment Model, Modality, 19 Countries' Data, Competitive Landscape - Analysis and Forecast, 2019-2029

出版商 BIS Research Inc. 商品編碼 911561
出版日期 內容資訊 英文 284 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
AI支援醫療圖像解決方案的全球市場 - 分析與預測:法規方案,工作流程,治療用途,部署模型,模式,19個國家的資料,競爭情形 (2019-2029年) Global AI-Enabled Medical Imaging Solutions Market: Focus on Regulatory Scenario, Workflow, Therapeutic Application, Deployment Model, Modality, 19 Countries' Data, Competitive Landscape - Analysis and Forecast, 2019-2029
出版日期: 2019年09月16日內容資訊: 英文 284 Pages
簡介

全球AI支援醫療圖像解決方案市場在2019年∼2029年間,預測將以30.95%的年複合成長率 (CAGR) 擴大。

本報告提供全球AI支援醫療圖像解決方案市場調查,市場概要,市場成長的各種影響因素分析,各市場區隔、各地區的分析與預測,及主要企業簡介等資訊彙整。

摘要整理

第1章 市場概要

第2章 市場動態

  • 概要
  • 影響分析
  • 市場成長的推動要素
  • 市場成長的阻礙因素
  • 市場機會

第3章 競爭情形

  • 主要策略、發展
  • 市場佔有率分析
    • 自主式軟體供應商
    • 顯像模式供應商
    • 平台供應商,IT及運算供應商
  • 成長佔有率分析
    • 各產品
    • 各工作流程
    • 各種模式
    • 各特殊影像

第4章 產業的考察

  • 產業生態系統
  • 法律規範
    • 北美
    • 歐洲
    • 其他各國
  • 醫生的認識

第5章 全球AI支援醫療圖像解決方案市場:各產品

  • 概要
  • 軟體
    • 永久許可證
    • 訂閱許可證
    • 每1事的收費軟體許可證
  • 硬體設備

第6章 全球AI支援醫療圖像解決方案市場:各工作流程

  • 概要
  • 影像分析
  • 影像獲得
  • 檢測
  • 匯報、通訊
  • 診斷、治療決策支援
  • 預測分析與風險評估
  • 分診
  • 設備維修

第7章 全球AI支援醫療圖像解決方案市場:各治療用途

  • 概要
  • 特殊影像
    • 心臟
    • 腫瘤
    • 神經
    • 呼吸系統
    • 整形外科
    • 其他
  • 一般影像

第8章 全球AI支援醫療圖像解決方案市場:各部署模式

  • 概要
  • 雲端、網站型解決方案
  • 內部部署解決方案

第9章 全球AI支援醫療圖像解決方案市場:各種模式

  • 概要
  • CT
  • MR
  • 超音波
  • X光
  • 乳房X光攝影
  • 多重模式成像系統
  • 其他模式

第10章 全球AI支援醫療圖像解決方案市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (ROW)

第11章 企業簡介

  • 概要
  • Aidoc
  • Arterys Inc.
  • Beijing Infervision Technology Co., Ltd.
  • Blackford Analysis Limited
  • ContextVision AB
  • EnvoyAI
  • FUJIFILM HOLDINGS CORPORATION
  • General Electric Company
  • iCAD, Inc.
  • Koninklijke Philips N.V.
  • MIRADA MEDICAL LIMITED
  • Nuance Communications, Inc.
  • NVIDIA Corporation
  • Resonance Health Ltd.
  • Samsung Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Synopsys, Inc.
  • Volpara Health Technologies Limited
  • VUNO lnc.
  • Zebra Medical Vision, Inc.

第12章 調查範圍、調查手法

目錄
Product Code: BH165A

"Global AI-Enabled Medical Imaging Solutions Market to Grow at a CAGR of 30.95% from 2019-2029."

Key Questions Answered in the Report:

  • How is the role of AI in enhancing the treatment pathways expected to evolve in the future?
  • Image Analysis is currently the leading clinical application incorporating AI-based solutions. Which clinical applications of AI are expected to emerge in the field of medical imaging?
  • How are the industry players trying to overcome the challenges associated with the workflow integration of AI?
  • What is the strongest return on investment (RoI) driver bolstering the incorporation of AI in medical imaging?
  • What are the steps taken by the industry players to overcome the challenge associated with data availability?
  • How are the current dominating stake conquered by autonomous software providers expected to be impacted due to the evolving perception of end users toward the incorporation of AI?
  • What are the key strategies incorporated by the leading players of global AI-enabled medical imaging solutions market to sustain the competition?
  • What is the current total market size and forecasts (until 2029) for different product categories available in the market?
  • What is the current total market size and forecasts (until 2029) for different AI-enabled solutions associated with each type of therapeutic application?
  • What is the scope of the global AI-enabled medical imaging solutions market in North America, Europe, Asia-Pacific, and Rest-of-the-World?
  • What is the role of each type of player in AI-enabled medical imaging solutions market?

Global AI-Enabled Medical Imaging Solutions Market, Forecast, 2019-2029

The AI-enabled medical imaging solutions industry analysis by BIS Research, projects the market to grow at a significant CAGR of 30.95% during the forecast period, 2019-2029. The global AI-enabled medical imaging solutions market generated $404.0 million revenue in 2018, in terms of value.

The market growth in the global AI-enabled medical imaging solutions market can primarily be attributed to the factors such as expanding range of applications of AI, shortage of healthcare workforce, and huge R&D investments as well as fundings. However, there are significant challenges which are restraining the market growth. These challenges include privacy and security concerns related to healthcare data and barriers to physician's adoption of AI.

Expert Quote

"AI has the potential to overcome the poor physician to patient ratio. The advent of deep learning algorithms has led to the development of novel AI solutions for use in the image analysis, decision support, and other areas of medical imaging."

Scope of the Market Intelligence on Global AI-Enabled Medical Imaging Solutions Market

The research report on global AI-enabled medical imaging solutions market provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the medical imaging market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global AI-enabled medical imaging solutions market.

Market Segmentation

The global AI-enabled medical imaging solutions market segmentation (on the basis of product) is further segmented into hardware and software.

The global AI-enabled medical imaging solutions market segmentation (on the basis of workflow) is segmented into image analysis, image acquisition, detection, reporting and communication, treatment decision support, triage, predictive analysis and risk assessment, and equipment maintenance.

The global AI-enabled medical imaging solutions market segmentation (on the basis of therapeutic application) is segmented into specialty imaging and general imaging.

The global AI-enabled medical imaging solutions market segmentation (on the basis of deployment model) is segmented into cloud and web-based solutions and on-premise solutions.

The global AI-enabled medical imaging solutions market segmentation (on the basis of modality) is segmented into computed tomography, magnetic resonance, ultrasound, X-ray, mammography, multimodality imaging systems, and others.

Key Companies in the Global AI-Enabled Medical Imaging Solutions Market:

The key manufacturers who have been contributing significantly to the global AI-enabled medical imaging market include Aidoc, Arterys Inc., Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, ContextVision AB, EnvoyAI, Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., MIRADA MEDICAL LIMITED, Nuance Communications, Inc., NVIDIA Corporation, Resonance Health Ltd., Samsung Electronics Co., Ltd., Siemens Healthineers AG, Synopsys Inc., Volpara Health Technologies Limited, VUNO Inc., and Zebra Medical Vision, Inc., among others.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Introduction
  • 1.2 Promising Potential of AI in Revolutionizing Medical Imaging
  • 1.3 Awaited Technological Advancements
  • 1.4 Global AI-Enabled Medical Imaging Solutions Market Scenario
    • 1.4.1 Global AI-Enabled Medical Imaging Solutions Addressable Market and Future Potential (2018-2029)
    • 1.4.2 Assumptions and Limitations

2 Market Dynamics

  • 2.1 Overview
  • 2.2 Impact Analysis
  • 2.3 Market Drivers
    • 2.3.1 Increasing Complexities of Clinical Decision-Making
    • 2.3.2 Expanding Range of Applications
    • 2.3.3 Shortage of Healthcare Workforce
    • 2.3.4 Huge R&D investment
  • 2.4 Market Restraints
    • 2.4.1 Privacy and Security Concerns Related to Healthcare Data
    • 2.4.2 Regulatory Challenges
    • 2.4.3 Barriers to Physician's Adoption of AI
  • 2.5 Market Opportunities
    • 2.5.1 Rapidly Evolving Deep Learning Techniques
    • 2.5.2 Increasing Number of Cross-Industry Partnerships
    • 2.5.3 Strong pipeline

3 Competitive Landscape

  • 3.1 Key Strategies and Developments
    • 3.1.1 Joint Ventures, Collaborations, and Partnerships
    • 3.1.2 Fundings and Investments
    • 3.1.3 Product Approvals
      • 3.1.3.1 U.S. FDA Approvals
      • 3.1.3.2 CE Mark Approvals
      • 3.1.3.3 PMDA Approvals
      • 3.1.3.4 Others
    • 3.1.4 Product Launches and Enhancements
    • 3.1.5 Mergers and Acquisitions
  • 3.2 Market Share Analysis
    • 3.2.1 Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (Autonomous Software Providers)
    • 3.2.2 Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (Imaging Modality Providers)
    • 3.2.3 Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (Platform Providers, IT, and Computing Vendors)
  • 3.3 Growth Share Analysis
    • 3.3.1 Growth Share Matrix (by Product)
    • 3.3.2 Growth Share Matrix (by Workflow)
    • 3.3.3 Growth Share Matrix (by Modality)
    • 3.3.4 Growth Share Matrix (by Specialty Imaging)

4 Industry Insights

  • 4.1 Industry Ecosystem
  • 4.2 Regulatory Framework
    • 4.2.1 North America
      • 4.2.1.1 Regulatory Requirements in the U.S.
      • 4.2.1.2 Regulatory Requirements in Canada
    • 4.2.2 Europe
    • 4.2.3 Other Countries
  • 4.3 Physicians' Perception

5 Global AI-Enabled Medical Imaging Solutions Market (by Product)

  • 5.1 Overview
  • 5.2 Software
    • 5.2.1 Perpetual Software License
    • 5.2.2 Subscription Software License
    • 5.2.3 Fee-Per Case Software License
  • 5.3 Hardware

6 Global AI-Enabled Medical Imaging Solutions Market (by Workflow)

  • 6.1 Overview
  • 6.2 Image Analysis
  • 6.3 Image Acquisition
  • 6.4 Detection
  • 6.5 Reporting and Communication
  • 6.6 Diagnosis and Treatment Decision Support
  • 6.7 Predictive Analysis and Risk Assessment
  • 6.8 Triage
  • 6.9 Equipment Maintenance

7 Global AI-Enabled Medical Imaging Solutions Market (by Therapeutic Application)

  • 7.1 Overview
  • 7.2 Specialty Imaging
    • 7.2.1 Cardiology
    • 7.2.2 Oncology
      • 7.2.2.1 Lung Cancer
      • 7.2.2.2 Breast Cancer
      • 7.2.2.3 Other Cancer Types
    • 7.2.3 Neurology
    • 7.2.4 Respiratory
    • 7.2.5 Orthopedics
    • 7.2.6 Others
  • 7.3 General Imaging

8 Global AI-Enabled Medical Imaging Solutions Market (by Deployment Model)

  • 8.1 Overview
  • 8.2 Cloud- and Web-Based Solutions
  • 8.3 On-Premise Solutions

9 Global AI-Enabled Medical Imaging Solutions Market (by Modality)

  • 9.1 Overview
  • 9.2 Computed Tomography (CT)
  • 9.3 Magnetic Resonance (MR)
  • 9.4 Ultrasound
  • 9.5 X-Ray
  • 9.6 Mammography
  • 9.7 Multimodality Imaging Systems
  • 9.8 Other Modalities

10 Global AI-Enabled Medical Imaging Solutions Market (by Region)

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 Market Footprint: North America AI-Enabled Medical Imaging Solutions Market
    • 10.2.2 North America AI-Enabled Medical Imaging Solutions Market, by Country
      • 10.2.2.1 U.S.
      • 10.2.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Market Footprint: Europe AI-Enabled Medical Imaging Solutions Market
    • 10.3.2 Europe AI-Enabled Medical Imaging Solutions Market, by Country
      • 10.3.2.1 U.K.
      • 10.3.2.2 Germany
      • 10.3.2.3 France
      • 10.3.2.4 Spain
      • 10.3.2.5 Italy
      • 10.3.2.6 Switzerland
      • 10.3.2.7 Sweden
      • 10.3.2.8 Netherlands
      • 10.3.2.9 Rest-of Europe
  • 10.4 Asia-Pacific
    • 10.4.1 Market Footprint: Asia-Pacific AI-Enabled Medical Imaging Solutions Market
    • 10.4.2 Asia-Pacific AI-Enabled Medical Imaging Solutions Market, by Country
      • 10.4.2.1 China
      • 10.4.2.2 Japan
      • 10.4.2.3 Australia and New Zealand
      • 10.4.2.4 South Korea
      • 10.4.2.5 India
      • 10.4.2.6 Singapore
      • 10.4.2.7 Rest-of-Asia-Pacific
  • 10.5 Rest-of-the-World (RoW)
    • 10.5.1 Market Footprint: Rest-of-the World AI-Enabled Medical Imaging Solutions Market
    • 10.5.2 Rest-of-the World AI-Enabled Medical Imaging Solutions Market, by Country
      • 10.5.2.1 Israel
      • 10.5.2.2 Brazil
      • 10.5.2.3 Mexico
      • 10.5.2.4 Others

11 Company Profiles

  • 11.1 Overview
  • 11.2 Aidoc
    • 11.2.1 Company Overview
    • 11.2.2 Role of Aidoc in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.2.3 SWOT Analysis: Aidoc
  • 11.3 Arterys Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Role of Arterys Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.3.3 SWOT Analysis: Arterys Inc.
  • 11.4 Beijing Infervision Technology Co., Ltd.
    • 11.4.1 Company Overview
    • 11.4.2 Role of Beijing Infervision Technology Co., Ltd. In the Global AI-Enabled Medical Imaging Solutions Market
    • 11.4.3 SWOT Analysis: Beijing Infervision Technology Co., Ltd.
  • 11.5 Blackford Analysis Limited
    • 11.5.1 Company Overview
    • 11.5.2 Role of Blackford Analysis Limited in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.5.3 SWOT Analysis: Blackford Analysis Limited
  • 11.6 ContextVision AB
    • 11.6.1 Company overview
    • 11.6.2 Role of ContextVision AB in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.6.3 Financials
      • 11.6.3.1 Key Insights on the Financial Health of the Company
    • 11.6.4 ContextVision AB: SWOT Analysis
  • 11.7 EnvoyAI
    • 11.7.1 Company Overview
    • 11.7.2 Role of EnvoyAI in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.7.3 SWOT Analysis: EnvoyAI
  • 11.8 Fujifilm Holdings Corporation
    • 11.8.1 Company overview
    • 11.8.2 Role of Fujifilm Holdings Corporation in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.8.3 Financials
      • 11.8.3.1 Key Insights on the Financial Health of the Company
    • 11.8.4 Fujifilm Holdings Corporation: SWOT Analysis
  • 11.9 General Electric Company
    • 11.9.1 Company overview
    • 11.9.2 Role of General Electric Company in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.9.3 Financials
      • 11.9.3.1 Key Insights on the Financial Health of the Company
    • 11.9.4 General Electric Company: SWOT Analysis
  • 11.10 iCAD, Inc.
    • 11.10.1 Company overview
    • 11.10.2 Role of iCAD, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.10.3 Financials
      • 11.10.3.1 Key Insights on the Financial Health of the Company
    • 11.10.4 iCAD, Inc.: SWOT Analysis
  • 11.11 Koninklijke Philips N.V.
    • 11.11.1 Company overview
    • 11.11.2 Role of Koninklijke Philips N.V. in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.11.3 Financials
      • 11.11.3.1 Key Insights on the Financial Health of the Company
    • 11.11.4 Koninklijke Philips N.V.: SWOT Analysis
  • 11.12 MIRADA MEDICAL LIMITED
    • 11.12.1 Company Overview
    • 11.12.2 Role of MIRADA MEDICAL LIMITED in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.12.3 SWOT Analysis: MIRADA MEDICAL LIMITED
  • 11.13 Nuance Communications, Inc.
    • 11.13.1 Company overview
    • 11.13.2 Role of Nuance Communications, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.13.3 Financials
      • 11.13.3.1 Key Insights on the Financial Health of the Company
    • 11.13.4 Nuance Communications, Inc.: SWOT Analysis
  • 11.14 NVIDIA Corporation
    • 11.14.1 Company overview
    • 11.14.2 Role of NVIDIA Corporation in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.14.3 Financials
      • 11.14.3.1 Key Insights on the Financial Health of the Company
    • 11.14.4 NVIDIA Corporation: SWOT Analysis
  • 11.15 Resonance Health Ltd.
    • 11.15.1 Company overview
    • 11.15.2 Role of Resonance Health Ltd. In the Global AI-Enabled Medical Imaging Solutions Market
    • 11.15.3 Financials
      • 11.15.3.1 Key Insights on the Financial Health of the Company
    • 11.15.4 Resonance Health Ltd.: SWOT Analysis
  • 11.16 Samsung Electronics Co., Ltd.
    • 11.16.1 Company overview
    • 11.16.2 Role of Samsung Electronics Co., Ltd. In the Global AI-Enabled Medical Imaging Solutions Market
    • 11.16.3 Financials
      • 11.16.3.1 Key Insights on the Financial Health of the Company
    • 11.16.4 Samsung Electronics Co., Ltd.: SWOT Analysis
  • 11.17 Siemens Healthineers AG
    • 11.17.1 Company overview
    • 11.17.2 Role of Siemens Healthineers AG in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.17.3 Financials
      • 11.17.3.1 Key Insights on the Financial Health of the Company
    • 11.17.4 Siemens Healthineers AG: SWOT Analysis
  • 11.18 Synopsys, Inc.
    • 11.18.1 Company overview
    • 11.18.2 Role of Synopsys, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.18.3 Financials
      • 11.18.3.1 Key Insights on the Financial Health of the Company
    • 11.18.4 Synopsys, Inc.: SWOT Analysis
  • 11.19 Volpara Health Technologies Limited
    • 11.19.1 Company overview
    • 11.19.2 Role of Volpara Health Technologies Limited in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.19.3 Financials
      • 11.19.3.1 Key Insights on the Financial Health of the Company
    • 11.19.4 Volpara Health Technologies Limited: SWOT Analysis
  • 11.20 VUNO lnc.
    • 11.20.1 Company Overview
    • 11.20.2 Role of VUNO lnc. In the Global AI-Enabled Medical Imaging Solutions Market
    • 11.20.3 SWOT Analysis: VUNO lnc.
  • 11.21 Zebra Medical Vision, Inc.
    • 11.21.1 Company Overview
    • 11.21.2 Role of Zebra Medical Vision, Inc. in the Global AI-Enabled Medical Imaging Solutions Market
    • 11.21.3 SWOT Analysis: Zebra Medical Vision, Inc.

12 Research Scope and Methodology

  • 12.1 Product Definition
  • 12.2 Scope of Research Study
  • 12.3 Global AI-Enabled Medical Imaging Solutions Market: Research Methodology

List of Tables

  • Table 2.1: Market Drivers
  • Table 2.2: Market Restraints
  • Table 2.3: List of AI-Enabled Medical Imaging Solutions in Pipeline
  • Table 3.1: List of FDA Approvals, January 2015-August 2019
  • Table 3.2: List of CE Mark Approvals, January 2015-August 2019
  • Table 3.3: List of Other Approvals, January 2015-August 2019
  • Table 9.1: List of Recently Approved AI-Enabled Mammography Solutions

List of Figures

  • Figure 1: Applications of AI in Healthcare
  • Figure 2: Impact Analysis of Market Drivers and Market Restraints, 2018-2029
  • Figure 3: Share of Key Developments and Strategies, January 2015-August 2019
  • Figure 4: Autonomous Software Providers Leading Global AI-Enabled Medical Imaging Solutions Market, 2018
  • Figure 5: Global AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 6: Global AI-Enabled Medical Imaging Solutions Market Share (By Product), 2018 and 2029
  • Figure 7: Global AI-Enabled Medical Imaging Solutions Market Share (By Workflow), 2018 and 2029
  • Figure 8: Global AI-Enabled Medical Imaging Solutions Market Share (By Therapeutic Application), 2018 and 2029
  • Figure 9: Global AI-Enabled Medical Imaging Solutions Market Share (By Specialty Imaging), 2018 and 2029
  • Figure 10: Global AI-Enabled Medical Imaging Solutions Market Share (By Deployment Model), 2018 and 2029
  • Figure 11: Global AI-Enabled Medical Imaging Solutions Market Share (By Modality), 2018 and 2029
  • Figure 12: Global AI-Enabled Medical Imaging Solutions Market Regional Snapshot
  • Figure 1.1: Applications of AI in Medical Imaging
  • Figure 1.2: Global AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 2.1: Top Ten Fundings in Global AI-Enabled Medical Imaging Solutions Market
  • Figure 3.1: Share of Key Developments and Strategies, January 2015-August 2019
  • Figure 3.2: Share of Joint Ventures, Collaborations, and Partnerships, January 2015-August 2019
  • Figure 3.3: Major Joint Ventures, Collaborations, and Partnerships: General Electric Company
  • Figure 3.4: Major Joint Ventures, Collaborations, and Partnerships: Siemens Healthineers AG
  • Figure 3.5: Share of Fundings and Investments, January 2015-August 2019
  • Figure 3.6: Share of Product Approvals, January 2015-August 2019
  • Figure 3.7: Share of Product Approvals (by Regulatory Body), January 2015-August 2019
  • Figure 3.8: Share of Product Launches and Enhancements, January 2015-August 2019
  • Figure 3.9: Share of Mergers and Acquisitions, January 2015-August 2019
  • Figure 3.10: Market Share Analysis, 2018
  • Figure 3.11: Market Share Analysis, 2017
  • Figure 3.12: Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (Autonomous Software Providers), 2018
  • Figure 3.13: Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (Autonomous Software Providers), 2017
  • Figure 3.14: Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (Imaging Modality Providers), 2018
  • Figure 3.15: Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (by Imaging Modality Providers), 2017
  • Figure 3.16: Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (Platform Providers, IT, and Computing Vendors), 2018
  • Figure 3.17: Market Share Analysis: Global AI-Enabled Medical Imaging Solutions Market (by Platform Providers, IT, and Computing Vendors), 2017
  • Figure 3.18: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Product), 2018-2029
  • Figure 3.19: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Workflow), 2018-2029
  • Figure 3.20: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Modality), 2018-2029
  • Figure 3.21: Growth Share Matrix: Global AI-Enabled Medical Imaging Solutions Market (by Specialty Imaging), 2018-2029
  • Figure 4.1: Industry Ecosystem
  • Figure 5.1: Global AI-Enabled Medical Imaging Solutions Market (by Product), 2018-2029
  • Figure 5.2: Global AI-Enabled Medical Imaging Solutions Market (by Software), 2018-2029
  • Figure 5.3: Global AI-Enabled Medical Imaging Solutions Market (Perpetual Software License), 2018-2029
  • Figure 5.4: Global AI-Enabled Medical Imaging Solutions Market (Subscription Software License), 2018-2029
  • Figure 5.5: Global AI-Enabled Medical Imaging Solutions Market (Fee-Per Case Software License), 2018-2029
  • Figure 5.6: Global AI-Enabled Medical Imaging Solutions Market (Hardware), 2018-2029
  • Figure 6.1: Global AI-Enabled Medical Imaging Solutions Market (by Workflow), 2018-2029
  • Figure 6.2: Global AI-Enabled Medical Imaging Solutions Market (Image Analysis), 2018-2029
  • Figure 6.3: Global AI-Enabled Medical Imaging Solutions Market (Image Acquisition), 2018-2029
  • Figure 6.4: Global AI-Enabled Medical Imaging Solutions Market (Detection), 2018-2029
  • Figure 6.5: Global AI-Enabled Medical Imaging Solutions Market (Reporting and Communication), 2018-2029
  • Figure 6.6: Global AI-Enabled Medical Imaging Solutions Market (Diagnosis and Treatment Decision Support), 2018-2029
  • Figure 6.7: Global AI-Enabled Medical Imaging Solutions Market (Predictive Analysis and Risk Assessment), 2018-2029
  • Figure 6.8: Global AI-Enabled Medical Imaging Solutions Market (Triage), 2018-2029
  • Figure 6.9: Global AI-Enabled Medical Imaging Solutions Market (Equipment Maintenance), 2018-2029
  • Figure 7.1: Global AI-Enabled Medical Imaging Solutions Market (Therapeutic Application), 2018-2029
  • Figure 7.2: Global AI-Enabled Medical Imaging Solutions Market (Specialty Imaging), 2018-2029
  • Figure 7.3: Global AI-Enabled Medical Imaging Solutions Market (Cardiology), 2018-2029
  • Figure 7.4: Applications of AI in Cancer Imaging
  • Figure 7.5: Global AI-Enabled Medical Imaging Solutions Market (Oncology), 2018-2029
  • Figure 7.6: Global AI-Enabled Medical Imaging Solutions Market (Lung Cancer), 2018-2029
  • Figure 7.7: Global AI-Enabled Medical Imaging Solutions Market (Breast Cancer), 2018-2029
  • Figure 7.8: Global AI-Enabled Medical Imaging Solutions Market (by Other Cancer Types), 2018-2029
  • Figure 7.9: Global AI-Enabled Medical Imaging Solutions Market (Neurology), 2018-2029
  • Figure 7.10: Global AI-Enabled Medical Imaging Solutions Market (Respiratory), 2018-2029
  • Figure 7.11: Global AI-Enabled Medical Imaging Solutions Market (Orthopedics), 2018-2029
  • Figure 7.12: Global AI-Enabled Medical Imaging Solutions Market (Others), 2018-2029
  • Figure 7.13: Global AI-Enabled Medical Imaging Solutions Market (General Imaging), 2018-2029
  • Figure 8.1: Global AI-Enabled Medical Imaging Solutions Market (by Deployment Model), 2018-2029
  • Figure 8.2: Global AI-Enabled Medical Imaging Solutions Market (by Cloud and Web-Based Solutions), 2018-2029
  • Figure 8.3: Global AI-Enabled Medical Imaging Solutions Market (by On-Premise Solutions), 2018-2029
  • Figure 9.1: Global AI-Enabled Medical Imaging Solutions Market (by Modality), 2018-2029
  • Figure 9.2: Global AI-Enabled Medical Imaging Solutions Market (by CT), 2018-2029
  • Figure 9.3: Global AI-Enabled Medical Imaging Solutions Market (by MR), 2018-2029
  • Figure 9.4: Global AI-Enabled Medical Imaging Solutions Market (by Ultrasound), 2018-2029
  • Figure 9.5: Global AI-Enabled Medical Imaging Solutions Market (by X-Ray), 2018-2029
  • Figure 9.6: Global AI-Enabled Medical Imaging Solutions Market (by Mammography), 2018-2029
  • Figure 9.7: Global AI-Enabled Medical Imaging Solutions Market (by Multimodality Imaging Systems), 2018-2029
  • Figure 9.8: Global AI-Enabled Medical Imaging Solutions Market (by Other Modalities), 2018-2029
  • Figure 10.1: Global AI-Enabled Medical Imaging Solutions Market Scenario, 2018 and 2028
  • Figure 10.2: North America: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.3: North America: Market Dynamics
  • Figure 10.4: North America: AI-Enabled Medical Imaging Solutions Market (by Country), 2018-2029
  • Figure 10.5: U.S.: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.6: Canada: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.7: Europe: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.8: Europe: Market Dynamics
  • Figure 10.9: Europe: AI-Enabled Medical Imaging Solutions Market (by Country), 2018-2029
  • Figure 10.10: U.K.: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.11: Germany: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.12: France: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.13: Spain: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.14: Italy: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.15: Switzerland: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.16: Sweden: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.17: Netherlands: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.18: Rest-of-Europe: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.19: Asia-Pacific: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.20: Asia-Pacific: Market Dynamics
  • Figure 10.21: Asia-Pacific: AI-Enabled Medical Imaging Solutions Market (by Country), 2018-2029
  • Figure 10.22: China: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.23: Japan: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.24: Australia and New Zealand: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.25: South Korea: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.26: India: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.27: Singapore: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.28: Rest-of-Asia-Pacific: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.29: Rest-of-the-World: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.30: Rest-of-the World: Market Dynamics
  • Figure 10.31: Rest-of-the World: AI-Enabled Medical Imaging Solutions Market (by Country), 2018-2029
  • Figure 10.32: Israel: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.33: Brazil: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.34: Mexico: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 10.35: Others: AI-Enabled Medical Imaging Solutions Market, 2018-2029
  • Figure 11.1: Shares of Key Company Profiles
  • Figure 11.2: Aidoc: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.3: Arterys Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.4: Beijing Infervision Technology Co., Ltd.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.5: Blackford Analysis Limited: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.6: ContextVision AB: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.7: ContextVision AB: Overall Financials, 2016-2018
  • Figure 11.8: ContextVision AB Net Revenue (by Business Segment), 2016-2018
  • Figure 11.9: ContextVision AB: Net Revenue (by Region), 2016-2018
  • Figure 11.10: ContextVision AB: R&D Expense, 2016-2018
  • Figure 11.11: EnvoyAI: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.12: Fujifilm Holdings Corporation: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.13: Fujifilm Holdings Corporation: Overall Financials, 2016-2018
  • Figure 11.14: Fujifilm Holdings Corporation Net Revenue (by Business Segment), 2016-2018
  • Figure 11.15: Fujifilm Holdings Corporation: Net Revenue (by Region), 2016-2018
  • Figure 11.16: Fujifilm Holdings Corporation: R&D Expense, 2016-2018
  • Figure 11.17: General Electric Company: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.18: General Electric Company: Overall Financials, 2016-2018
  • Figure 11.19: General Electric Company Net Revenue (by Business Segment), 2016-2018
  • Figure 11.20: General Electric Company: Net Revenue (by Region), 2016-2018
  • Figure 11.21: General Electric Company: R&D Expense, 2016-2018
  • Figure 11.22: iCAD, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.23: iCAD, Inc.: Overall Financials, 2016-2018
  • Figure 11.24: iCAD, Inc. Net Revenue (by Business Segment), 2016-2018
  • Figure 11.25: iCAD, Inc.: R&D Expense, 2016-2018
  • Figure 11.26: Koninklijke Philips N.V.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.27: Koninklijke Philips N.V.: Overall Financials, 2016-2018
  • Figure 11.28: Koninklijke Philips N.V. Net Revenue (by Business Segment), 2016-2018
  • Figure 11.29: Koninklijke Philips N.V.: Net Revenue (by Region), 2016-2018
  • Figure 11.30: Koninklijke Philips N.V.: R&D Expense, 2016-2018
  • Figure 11.31: MIRADA MEDICAL LIMITED: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.32: Nuance Communications, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.33: Nuance Communications, Inc.: Overall Financials, 2016-2018
  • Figure 11.34: Nuance Communications, Inc. Net Revenue (by Business Segment), 2016-2018
  • Figure 11.35: Nuance Communications, Inc.: R&D Expense, 2016-2018
  • Figure 11.36: NVIDIA Corporation: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.37: NVIDIA Corporation: Overall Financials, 2016-2018
  • Figure 11.38: NVIDIA Corporation Net Revenue (by Business Segment), 2016-2018
  • Figure 11.39: NVIDIA Corporation: Net Revenue (by Region), 2016-2018
  • Figure 11.40: NVIDIA Corporation: R&D Expense, 2016-2018
  • Figure 11.41: Resonance Health Ltd.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.42: Resonance Health Ltd.: Overall Financials, 2016-2018
  • Figure 11.43: Resonance Health Ltd. Net Revenue (by Business Segment), 2016-2018
  • Figure 11.44: Resonance Health Ltd.: Net Revenue (by Region), 2016-2018
  • Figure 11.45: Resonance Health Ltd.: R&D Expense, 2016-2018
  • Figure 11.46: Samsung Electronics Co., Ltd.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.47: Samsung Electronics Co., Ltd.: Overall Financials, 2016-2018
  • Figure 11.48: Samsung Electronics Co., Ltd. Net Revenue (by Business Segment), 2016-2018
  • Figure 11.49: Samsung Electronics Co., Ltd.: Net Revenue (by Region), 2016-2018
  • Figure 11.50: Samsung Electronics Co., Ltd.: R&D Expense, 2016-2018
  • Figure 11.51: Siemens Healthineers AG: Product Offerings for the Global AI- Enabled Medical Imaging Solutions Market
  • Figure 11.52: Siemens Healthineers AG: Overall Financials, 2016-2018
  • Figure 11.53: Siemens Healthineers AG Net Revenue (by Business Segment), 2016-2018
  • Figure 11.54: Siemens Healthineers AG: Net Revenue (by Region), 2016-2018
  • Figure 11.55: Siemens Healthineers AG: R&D Expense, 2016-2018
  • Figure 11.56: Synopsys, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.57: Synopsys, Inc.: Overall Financials, 2016-2018
  • Figure 11.58: Synopsys, Inc.: Net Revenue (by Region), 2016-2018
  • Figure 11.59: Synopsys, Inc.: R&D Expense, 2016-2018
  • Figure 11.60: Volpara Health Technologies Limited: Overall Financials, 2016-2018
  • Figure 11.61: Volpara Health Technologies Limited Net Revenue (by Business Segment), 2016-2018
  • Figure 11.62: Volpara Health Technologies Limited: Net Revenue (by Region), 2016-2018
  • Figure 11.63: Volpara Health Technologies Limited: R&D Expense, 2016-2018
  • Figure 11.64: VUNO lnc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 11.65: Zebra Medical Vision, Inc.: Product Offerings for the Global AI-Enabled Medical Imaging Solutions Market
  • Figure 12.1: Global AI-Enabled Medical Imaging Solutions Market Segmentation
  • Figure 12.2: Research Methodology
  • Figure 12.3: Primary Research
  • Figure 12.4: Secondary Research
  • Figure 12.5: Data Triangulation
  • Figure 12.6: Bottom-up Approach (Segment-wise Analysis)
  • Figure 12.7: Top-Down Approach (Segment-wise Analysis)
  • Figure 12.8: Assumptions and Limitations
  • Figure 12.9: Considered Factors for Data Prediction and Modeling
Back to Top